Market Tracker

12/15 5:15pm ET

Sangamo Therapeutics Inc (NASDAQ:SGMO)

16.35
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
2.85
Today|||52-Week Range
18.40
+436.07%
Year-to-Date

Today’s Trading

Previous close16.35
Today’s open16.45
Day’s range16.00 - 16.70
Volume2,651,008
Average volume (3 months)1,709,444
Market cap$1.4B
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)+29.09%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book8.53

Competitors

----
EPZMEpizyme Inc0.000.00%
RTRXRetrophin Inc0.000.00%
FPRXFive Prime Therapeut...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts